Trials / Completed
CompletedNCT01874132
Study of the Long-term Effects of Exercise on Heath Indicators in Older People
A Randomised Longitudinal Study of Exercise Prescription for Older Adults: Mode and Intensity to Induce the Highest Cardiovascular Health-related Benefits
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 66 (actual)
- Sponsor
- University of Trás-os-Montes and Alto Douro · Academic / Other
- Sex
- Male
- Age
- 65 Years – 79 Years
- Healthy volunteers
- Accepted
Summary
Cardiovascular diseases (CVD) represent the most frequent cause of death among the elderly population. Hypertension, unfavorable lipid profile, obesity and physical inactivity are among the main risk factors for CVD. In contrast, mortality from CVD is inversely related to levels of physical activity, and is lower in individuals who exercise and have higher functional fitness levels. Thus, the Centers for Disease Control and Prevention, the American College of Sports Medicine, and the American Heart Association have recommended 20-30 min of moderate-to-vigorous aerobic training for the elderly, preferably every day or at least 3 days a week in the case of vigorous exercise.The same organizations also suggest the inclusion of resistance training in order to improve functional fitness. Therefore, the purpose of this study was to compare different exercise modalities in long-term changes of CVD risk factors and physical fitness among older adults.
Conditions
- Hypertension With Complications and Secondary Hypertension
- Overweight and Obesity
- Lipid Metabolism Disorders
- Sarcopenia
- Osteoporosis
- Personal Satisfaction
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Exercise training | Both training programs were of moderate-to-vigorous intensity, three days per week for nine months. |
Timeline
- Start date
- 2011-05-01
- Primary completion
- 2011-09-01
- Completion
- 2014-09-01
- First posted
- 2013-06-10
- Last updated
- 2017-05-08
- Results posted
- 2016-12-12
Locations
1 site across 1 country: Portugal
Source: ClinicalTrials.gov record NCT01874132. Inclusion in this directory is not an endorsement.